Bioxcel therapeutics to report first quarter 2023 financial results on may 8, 2023

New haven, conn., april 24, 2023 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its first quarter 2023 financial results on monday, may 8, 2023 before the open of the u.s. financial markets. bioxcel therapeutics' management team will also host a conference call and webcast at 8:00 am et that day to discuss the company's financial results and to provide a general business update.
BTAI Ratings Summary
BTAI Quant Ranking